skip to main content
Main Site Navigation
Top of main content

Currently Enrolling Clinical Studies

The following clinical studies are currently enrolling participants in the Greater Peoria area. To learn more about clinical research at Carle Health Methodist Hospital or to enroll in a study, please call the research office at (309) 672-3118.


Heart and Vascular Research


AMBER - Heart Failure
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CK-4021586 in Adults with Symptomatic Heart Failure with Preserved Ejection Fraction (Cytokinetics CY 9021; AMBER-HFpEF Study)
For more information, call (309) 672-3118.

Principal investigator: Alexander Adler, MD

REDEFINE-HF – Heart Failure
RandomizED trial to DEtermine the efficacy and safety of FINErenone on morbidity and mortality among heart failure patients with left ventricular ejection fraction greater than or equal to 40% hospitalized due to an episode of acute decompensated Heart Failure (REDEFINE-HF)
For more information, call (309) 672-3118.
Principal investigator: Alexander Adler, MD

FINALITY-HF – Heart Failure
A randomized, double-blind, placebo-controlled pragmatic study to evaluate FINerenone on clinicAL efficacy and safeTY in patients with Heart Failure and reduced ejection fraction who are intolerant of or not eligible for treatment with steroidal mineralocorticoid receptor antagonists
For more information, call (309) 672-3118.
Principal investigator: Alexander Adler, MD

CONFIRMATION-HF – Heart Failure
COmbiNed eFfIcacy and safety of an eaRly MAnagement sTrategy with flnerenOne and SGLT2 iNhibitor in patients hospitalized with Heart Failure (CONFIRMATION-HF)
For more information, call (309) 672-3118.
Principal investigator: Alexander Adler, MD


SSCORE - SSO2 Therapy
SuperSaturated Oxygen Comprehensive Observational REgistry (SSCORE)
For more information, call (309) 672-3118.
Principal investigator: Surya Chaturvedula, MD

HERMES – Heart Failure and Inflammation
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People with Heart Failure and Inflammation
For more information, call (309) 672-3118.
Principal investigator: Alexander Adler, MD

 Imaging Research


ODYSSEY – MRI and Motor/Cognitive Function
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
For more information, call Camryn at (309) 672-3118.
Principal investigator: Praveen Sudhindra, MD

 



 Meet Our Team


Vaughn Hanna, MD
Medical Director

Savannah Hammerl
Clinical Research Manager
savannah.hammerl@carle.com | (309) 672-3118

Camryn Picken
Clinical Research Coordinator II
camryn.picken@carle.com | (309) 672-4808

Andrea Fugitt
Clinical Research Coordinator II
andrea.fugitt@carle.com | (309) 672-3194

Amanda Strausbaugh
Clinical Research Coordinator II
amanda.strausbaugh@carle.com | (309) 672-3156


Victoria Graf
Clinical Research Coordinator II
victoria.graf@carle.com | (309) 672-4767